臨床試驗

Efficacy of Rapamycin in the Treatment of Cervico-facial Lymphatic Malformations

NCT：NCT03243019 · RECRUITING

NCT IDNCT03243019

狀態RECRUITING

開始日期2018-06-25

SponsorUniversity Hospital, Lille (OTHER)

First posted2017-08-08

Last updated2026-05-22

簡要摘要

To evaluate the efficacy of Rapamycin in extended cervicofacial lymphatic malformations in pediatric patients. Rapamycin is administered oral for a 6 month period. The success rate is determined by volume reduction superior to 1/5e of the initial volume measured by MRI, impact on QOL and reduction of bleeding in case of mucosal involvement.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。